Quotient Therapeutics Limited
14042800
Healthy
- No accounts filed in last 18 months (-5)
- 1 outstanding charge (-2)
Details
Previously known as
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 12/04/2026
Due 26/04/2027
Industry
Officers
Former
director · Resigned 19/03/2025
director · Resigned 24/04/2026
Persons with Significant Control
Former PSCs
Flagship Labs 86, Inc.
Ceased 12/04/2022
Charges1 outstanding
HSBC INNOVATION BANKING
Change History
Active
Private Limited Company
SUITE 4, 7TH FLOOR
LONDON
CompanyRankvs 279+ SIC 72110 peers69
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£3.4M
Balance sheet strength
Cash
£814k
Cash in the bank
Net Current Assets
£2.7M
Working capital
Current Assets
£4.1M
Current Liabilities
£1.5M
Fixed Assets
£1.5M
Debtors
£183k
Profit After Tax
£916k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.84 | +£1.5M |
| 2023 | 2.51 | — |
Derived from filed accounts. Not audited figures.